The NHS Health Research Authority (HRA) is working to ensure that new COVID-19 research studies can start as quickly as possible while maintaining high standards of research practice.
The HRA is using a fast-track review process with bespoke advice and support for researchers. The average review timeline is 5 days, with many completed within 24 to 72 hours.
They have updated the information on their website about the fast-track review process, guidance for researchers, sites and sponsors, guidance about using confidential patient data without consent, and information about how we are handling other types of research.
The HRA review takes place in parallel with the Chief Medical Officer’s prioritisation process for COVID studies.
There is a list of approved studies on the HRA website.